Amber KT, Murrell DF, Schmidt E, Joly P, Borradori L. Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management. Clin Rev Allergy Immunol. 2018;54(1):26–51.
Witte M, Zillikens D, Schmidt E. Diagnosis of autoimmune blistering diseases. Front Med. 2018;5:296.
Egami S, Yamagami J, Amagai M. Autoimmune bullous skin diseases, pemphigus and pemphigoid. J Allergy Clin Immunol. 2020;145(4):1031–47.
Chou C-S. Childhood bullous pemphigoid: a case report and literature review. J Clin Exp Dermatol Res. 2014. https://doi.org/10.4172/2155-9554.S6-010.
Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2020;40(1):24–64.
Azizi G, Ziaee V, Tavakol M, Alinia T, Yazdai R, Mohammadi H, et al. Approach to the management of autoimmunity in primary immunodeficiency. Scand J Immunol. 2017;85(1):13–29.
Abinun MAM, Beaussant Cohen S, Buckland M, Bustamante J, Cant AJ, et al. ESID registry - Working definitions for clinical diagnosis of PID. https://esid.org/Working-Parties/Registry-Working-Party/Diagnosis-criteria. Accessed 22 Nov 2022.
Salzer E, Cagdas D, Hons M, Mace EM, Garncarz W, Petronczki ÖY, et al. RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics. Nat Immunol. 2016;17(12):1352–60.
Ozen A, Comrie WA, Ardy RC, Domínguez Conde C, Dalgic B, Beser ÖF, et al. CD55 deficiency, early-onset protein-losing enteropathy, and thrombosis. N Engl J Med. 2017;377(1):52–61.
Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310–5.
Sharma D, Jindal AK, Rawat A, Singh S. Approach to a child with primary immunodeficiency made simple. Indian Dermatol Online J. 2017;8(6):391–405.
Nemeth AJ, Klein AD, Gould EW, Schachner LA. Childhood bullous pemphigoid Clinical and immunologic features, treatment, and prognosis. Arch Dermatol. 1991;127(3):378–86.
Bloomfield S, Stockdill G, Barnetson RS. Thymic hypoplasia, auto-immune haemolytic anaemia and juvenile pemphigoid in an infant. Br J Dermatol. 1982;106(3):353–5.
Rosenberg JM, Maccari ME, Barzaghi F, Allenspach EJ, Pignata C, Weber G, et al. Neutralizing anti-cytokine autoantibodies against interferon-α in immunodysregulation polyendocrinopathy enteropathy X-linked. Front Immunol. 2018;9:544.
Ferguson PJ, Blanton SH, Saulsbury FT, McDuffie MJ, Lemahieu V, Gastier JM, et al. Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome. Am J Med Genet. 2000;90(5):390–7.
McGinness JL, Bivens MM, Greer KE, Patterson JW, Saulsbury FT. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature. J Am Acad Dermatol. 2006;55(1):143–8.
Goudy K, Aydin D, Barzaghi F, Gambineri E, Vignoli M, Ciullini Mannurita S, et al. Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity. Clin Immunol. 2013;146(3):248–61.
Barzaghi F, Passerini L, Gambineri E, Ciullini Mannurita S, Cornu T, Kang ES, et al. Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome. J Autoimmun. 2012;38(1):49–58.
Budiyani L, Idayu A, Wijaya I, Widhani A. Sindrom Hiper IgE dengan manifestasi bullous pemphigoid dan striktur esofagus. J Penyakit Dalam Indonesia. 2016;3:100.
Erbagci Z. Childhood bullous pemphigoid in association with hyperimmunoglobulin E syndrome. Pediatr Dermatol. 2008;25(1):28–33.
Chan AY, Punwani D, Kadlecek TA, Cowan MJ, Olson JL, Mathes EF, et al. A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70. J Exp Med. 2016;213(2):155–65.
Doll R, Johnson J, Tcheurekdjian H, Hostoffer R. Common variable immune deficiency associated with pemphigoid. Ann Allergy Asthma Immunol. 2017;118(1):122.
Sillevis Smitt JH, Leusen JH, Stas HG, Teeuw AH, Weening RS. Chronic bullous disease of childhood and a paecilomyces lung infection in chronic granulomatous disease. Arch Dis Child. 1997;77(2):150–2.
Neves JF, Doffinger R, Barcena-Morales G, Martins C, Papapietro O, Plagnol V, et al. Novel PLCG2 mutation in a patient with APLAID and cutis laxa. Front Immunol. 2018;9:2863.
Serpa FS, Veronez CL, Campinhos FL, Moyses TR, Pesquero JB. SERPING1 mutation in a rare hereditary angioedema with skin blisters. Ann Allergy Asthma Immunol. 2019;122(3):340–1.
Schultz B, Hook K. Bullous diseases in children: a review of clinical features and treatment options. Paediatr Drugs. 2019;21(5):345–56.
Jamee M, Zaki-Dizaji M, Lo B, Abolhassani H, Aghamahdi F, Mosavian M, et al. Clinical, immunological, and genetic features in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-like syndrome. J Allergy Clin Immunol Pract. 2020. https://doi.org/10.1016/j.jaip.2020.04.070.
Muramatsu K, Ujiie H, Kobayashi I, Nishie W, Izumi K, Ito T, et al. Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects. J Allergy Clin Immunol. 2018;142(6):1818-30.e6.
Yang L, Fliegauf M, Grimbacher B. Hyper-IgE syndromes: reviewing PGM3 deficiency. Curr Opin Pediatr. 2014;26(6):697–703.
Stray-Pedersen A, Backe PH, Sorte HS, Mørkrid L, Chokshi NY, Erichsen HC, et al. PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia. Am J Hum Genet. 2014;95(1):96–107.
Bernth-Jensen JM, Holm M, Christiansen M. Neonatal-onset T(-)B(-)NK(+) severe combined immunodeficiency and neutropenia caused by mutated phosphoglucomutase 3. J Allergy Clin Immunol. 2016;137(1):321–4.
Pacheco-Cuéllar G, Gauthier J, Désilets V, Lachance C, Lemire-Girard M, Rypens F, et al. A novel PGM3 mutation is associated with a severe phenotype of bone marrow failure, severe combined immunodeficiency, skeletal dysplasia, and congenital malformations. J Bone Mineral Res. 2017;32(9):1853–9.
Fusaro M, Vincent A, Castelle M, Rosain J, Fournier B, Veiga-da-Cunha M, et al. Two novel homozygous mutations in phosphoglucomutase 3 leading to severe combined immunodeficiency, skeletal dysplasia, and malformations. J Clin Immunol. 2021. https://doi.org/10.1007/s10875-021-00985-w.
Abolhassani H, Chou J, Bainter W, Platt CD, Tavassoli M, Momen T, et al. Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency. J Allergy Clin Immunol. 2018;141(4):1450–8.
留言 (0)